Cat. No.: HY-149896

Antitumor agent-107

Antitumor agent-107 (compound 5h) is an anticancer agent that shows excellent inhibitory activity against leukemia cell lines (GI₅₀=0.32-1.34 μM). Antitumor agent-107 also shows antitumor activity against various other human cancer cell lines (GI₅₀ range 0.35-9.43 μM).

For research use only. We do not sell to patients.

CAS No.: 3052360-22-9
Formula: C₂₈H₂₁N₃O₂
Molecular Weight:431.49

Storage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (273 KB)

Antitumor agent-107 Chemical Structure

CAS No.: 3052360-22-9

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- Cellular Effect
Chemical Information
Protocols (1)
Purity & Documentation
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

Description

Cellular Effect

Cell Line	Type	Value	Description	References
786-0	GI₅₀	1.57 μM Compound: 5h; NSC 830655	Antiproliferative activity against human 786-0 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human 786-0 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
A498	GI₅₀	0.65 μM Compound: 5h; NSC 830655	Antiproliferative activity against human A498 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human A498 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
A549	GI₅₀	0.58 μM Compound: 5h; NSC 830655	Antiproliferative activity against human A549 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human A549 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
ACHN	GI₅₀	0.46 μM Compound: 5h; NSC 830655	Antiproliferative activity against human ACHN cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human ACHN cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
BT-549	GI₅₀	2.27 μM Compound: 5h; NSC 830655	Antiproliferative activity against human BT-549 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human BT-549 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
CAKI-1	GI₅₀	0.55 μM Compound: 5h; NSC 830655	Antiproliferative activity against human CAKI-1 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human CAKI-1 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
CCRF-CEM	GI₅₀	0.55 μM Compound: 5h; NSC 830655	Antiproliferative activity against human CCRF-CEM cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human CCRF-CEM cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
CCRF-CEM	GI₅₀	2.9 μM Compound: 5h; NSC 830655	Anti-leukemic activity against human CCRF-CEM cells assessed as cell growth inhibition Anti-leukemic activity against human CCRF-CEM cells assessed as cell growth inhibition	[PMID: 37437350]
COLO 205	GI₅₀	0.62 μM Compound: 5h; NSC 830655	Antiproliferative activity against human COLO 205 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human COLO 205 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
DU-145	GI₅₀	2.16 μM Compound: 5h; NSC 830655	Antiproliferative activity against human DU-145 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human DU-145 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
EKVX	GI₅₀	2.79 μM Compound: 5h; NSC 830655	Antiproliferative activity against human EKVX cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human EKVX cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
HCC 2998	GI₅₀	1.62 μM Compound: 5h; NSC 830655	Antiproliferative activity against human HCC 2998 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human HCC 2998 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
HCT-116	GI₅₀	1.66 μM Compound: 5h; NSC 830655	Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
HCT-15	GI₅₀	0.92 μM Compound: 5h; NSC 830655	Antiproliferative activity against human HCT-15 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human HCT-15 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
HL-60	GI₅₀	1.2 μM Compound: 5h; NSC 830655	Anti-leukemic activity against human HL-60 cells assessed as cell growth inhibition Anti-leukemic activity against human HL-60 cells assessed as cell growth inhibition	[PMID: 37437350]
HL-60(TB)	GI₅₀	0.41 μM Compound: 5h; NSC 830655	Antiproliferative activity against human HL-60(TB) cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human HL-60(TB) cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
HOP-62	GI₅₀	0.65 μM Compound: 5h; NSC 830655	Antiproliferative activity against human HOP-62 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human HOP-62 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
HOP-92	GI₅₀	1.65 μM Compound: 5h; NSC 830655	Antiproliferative activity against human HOP-92 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human HOP-92 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
Hs-578T	GI₅₀	1.42 μM Compound: 5h; NSC 830655	Antiproliferative activity against human Hs-578T cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human Hs-578T cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
HT-29	GI₅₀	1.91 μM Compound: 5h; NSC 830655	Antiproliferative activity against human HT-29 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human HT-29 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
IGROV-1	GI₅₀	1.48 μM Compound: 5h; NSC 830655	Antiproliferative activity against human IGROV-1 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human IGROV-1 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
K562	GI₅₀	1.32 μM Compound: 5h; NSC 830655	Antiproliferative activity against human K562 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human K562 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
KM12	GI₅₀	9.43 μM Compound: 5h; NSC 830655	Antiproliferative activity against human KM12 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human KM12 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
LOX IMVI	GI₅₀	0.97 μM Compound: 5h; NSC 830655	Antiproliferative activity against human LOX IMVI cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human LOX IMVI cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
M14	GI₅₀	2.08 μM Compound: 5h; NSC 830655	Antiproliferative activity against human M14 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human M14 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
Malme-3M	GI₅₀	0.88 μM Compound: 5h; NSC 830655	Antiproliferative activity against human Malme-3M cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human Malme-3M cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
MCF7	GI₅₀	0.5 μM Compound: 5h; NSC 830655	Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
MDA-MB-231	GI₅₀	1.52 μM Compound: 5h; NSC 830655	Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
MDA-MB-435	GI₅₀	2.72 μM Compound: 5h; NSC 830655	Antiproliferative activity against human MDA-MB-435 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human MDA-MB-435 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
MDA-MB-468	GI₅₀	2.7 μM Compound: 5h; NSC 830655	Antiproliferative activity against human MDA-MB-468 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human MDA-MB-468 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
MOLM-13	GI₅₀	0.9 μM Compound: 5h; NSC 830655	Anti-leukemic activity against human MOLM-13 cells assessed as cell growth inhibition Anti-leukemic activity against human MOLM-13 cells assessed as cell growth inhibition	[PMID: 37437350]
MOLT-4	GI₅₀	0.35 μM Compound: 5h; NSC 830655	Antiproliferative activity against human MOLT-4 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human MOLT-4 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
MV4-11	GI₅₀	0.8 μM Compound: 5h; NSC 830655	Anti-leukemic activity against human MV4-11 cells assessed as cell growth inhibition Anti-leukemic activity against human MV4-11 cells assessed as cell growth inhibition	[PMID: 37437350]
NCI/ADR-RES	GI₅₀	2.07 μM Compound: 5h; NSC 830655	Antiproliferative activity against human NCI/ADR-RES cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human NCI/ADR-RES cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
NCI-H226	GI₅₀	1.16 μM Compound: 5h; NSC 830655	Antiproliferative activity against human NCI-H226 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human NCI-H226 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
NCI-H23	GI₅₀	1.92 μM Compound: 5h; NSC 830655	Antiproliferative activity against human NCI-H23 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human NCI-H23 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
NCI-H322M	GI₅₀	7.36 μM Compound: 5h; NSC 830655	Antiproliferative activity against human NCI-H322M cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human NCI-H322M cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
NCI-H460	GI₅₀	0.35 μM Compound: 5h; NSC 830655	Antiproliferative activity against human NCI-H460 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human NCI-H460 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
NCI-H522	GI₅₀	2.75 μM Compound: 5h; NSC 830655	Antiproliferative activity against human NCI-H522 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human NCI-H522 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
OVCAR-4	GI₅₀	4.77 μM Compound: 5h; NSC 830655	Antiproliferative activity against human OVCAR-4 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human OVCAR-4 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
OVCAR-5	GI₅₀	3.03 μM Compound: 5h; NSC 830655	Antiproliferative activity against human OVCAR-5 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human OVCAR-5 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
OVCAR-8	GI₅₀	1.06 μM Compound: 5h; NSC 830655	Antiproliferative activity against human OVCAR-8 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human OVCAR-8 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
PC-3	GI₅₀	2.5 μM Compound: 5h; NSC 830655	Antiproliferative activity against human PC-3 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human PC-3 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
RPMI-8226	GI₅₀	1.34 μM Compound: 5h; NSC 830655	Antiproliferative activity against human RPMI-8226 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human RPMI-8226 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
RXF 393	GI₅₀	2.75 μM Compound: 5h; NSC 830655	Antiproliferative activity against human RXF 393 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human RXF 393 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
SF-268	GI₅₀	1.95 μM Compound: 5h; NSC 830655	Antiproliferative activity against human SF-268 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human SF-268 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
SF-295	GI₅₀	0.58 μM Compound: 5h; NSC 830655	Antiproliferative activity against human SF-295 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human SF-295 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
SF-539	GI₅₀	1.02 μM Compound: 5h; NSC 830655	Antiproliferative activity against human SF-539 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human SF-539 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
SK-MEL-2	GI₅₀	2.57 μM Compound: 5h; NSC 830655	Antiproliferative activity against human SK-MEL-2 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human SK-MEL-2 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
SK-MEL-28	GI₅₀	2.88 μM Compound: 5h; NSC 830655	Antiproliferative activity against human SK-MEL-28 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human SK-MEL-28 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
SK-MEL-5	GI₅₀	0.96 μM Compound: 5h; NSC 830655	Antiproliferative activity against human SK-MEL-5 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human SK-MEL-5 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
SK-OV-3	GI₅₀	2.55 μM Compound: 5h; NSC 830655	Antiproliferative activity against human SK-OV-3 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human SK-OV-3 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
SN12C	GI₅₀	1.33 μM Compound: 5h; NSC 830655	Antiproliferative activity against human SN12C cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human SN12C cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
SNB-19	GI₅₀	2.59 μM Compound: 5h; NSC 830655	Antiproliferative activity against human SNB-19 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human SNB-19 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
SNB-75	GI₅₀	0.86 μM Compound: 5h; NSC 830655	Antiproliferative activity against human SNB-75 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human SNB-75 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
SR	GI₅₀	0.36 μM Compound: 5h; NSC 830655	Antiproliferative activity against human SR cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human SR cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
SW-620	GI₅₀	0.78 μM Compound: 5h; NSC 830655	Antiproliferative activity against human SW-620 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human SW-620 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
T47D	GI₅₀	1.73 μM Compound: 5h; NSC 830655	Antiproliferative activity against human T47D cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human T47D cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
THP-1	GI₅₀	2.8 μM Compound: 5h; NSC 830655	Anti-leukemic activity against human THP-1 cells assessed as cell growth inhibition Anti-leukemic activity against human THP-1 cells assessed as cell growth inhibition	[PMID: 37437350]
TK-10	GI₅₀	2.47 μM Compound: 5h; NSC 830655	Antiproliferative activity against human TK-10 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human TK-10 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
U-251	GI₅₀	1.16 μM Compound: 5h; NSC 830655	Antiproliferative activity against human U-251 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human U-251 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
UACC-257	GI₅₀	2.14 μM Compound: 5h; NSC 830655	Antiproliferative activity against human UACC-257 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human UACC-257 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
UACC-62	GI₅₀	1.03 μM Compound: 5h; NSC 830655	Antiproliferative activity against human UACC-62 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human UACC-62 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]
UO-31	GI₅₀	0.67 μM Compound: 5h; NSC 830655	Antiproliferative activity against human UO-31 cells assessed as cell growth inhibition by SRB assay Antiproliferative activity against human UO-31 cells assessed as cell growth inhibition by SRB assay	[PMID: 37437350]

Chemical Information

CAS No. 3052360-22-9
Molecular Weight 431.49
Formula C₂₈H₂₁N₃O₂
SMILES

COC1=C(C=CC(C2=NC3=NC4=C(C=CC=C4)N3C(C5=CC=CC6=C5C=CC=C6)=C2)=C1)OC
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Protocols

All Animals and Diseases

Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (273 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Moataz A. Shaldam, et al. 2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling. Eur J Med Chem. 2023 Oct 5.

Calculators

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

Antitumor agent-107

Biological Activity

Description

Cellular Effect

Chemical Information

Protocols

Purity & Documentation

References

Calculators

Help & FAQs

Bioz

Keywords

Your Recently Viewed Products

Antitumor agent-107

Biological Activity

Description

Cellular Effect

Chemical Information

Protocols

Purity & Documentation

References

Calculators

Help & FAQs